HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueli Pang Selected Research

CpG ODN107

1/2016TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells.
10/2012CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueli Pang Research Topics

Disease

14Neoplasms (Cancer)
03/2017 - 12/2011
7Breast Neoplasms (Breast Cancer)
03/2017 - 12/2013
5Neoplasm Metastasis (Metastasis)
10/2016 - 03/2012
3Colonic Neoplasms (Colon Cancer)
09/2017 - 07/2013
3Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 03/2012
2Colorectal Neoplasms (Colorectal Cancer)
05/2016 - 01/2016
2Glioma (Gliomas)
01/2016 - 10/2012
2Nasopharyngeal Carcinoma
11/2015 - 03/2012
1Infections
01/2020
1Kidney Diseases (Kidney Disease)
11/2017
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
11/2017
1Leukemia
09/2017
1Lymphoma (Lymphomas)
09/2017
1Type 2 Diabetes Mellitus (MODY)
03/2017
1Neutropenia
11/2015
1Anemia
11/2015
1Thrombocytopenia (Thrombopenia)
11/2015
1Lymphatic Metastasis
01/2015
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
07/2002
1Chromosome Aberrations (Chromosome Abnormalities)
07/2002

Drug/Important Bio-Agent (IBA)

5LeptinIBA
10/2016 - 12/2013
4Interleukin-8 (Interleukin 8)IBA
10/2016 - 01/2015
3Proteins (Proteins, Gene)FDA Link
09/2017 - 05/2016
3theasinensin AIBA
01/2016 - 07/2013
2MicroRNAs (MicroRNA)IBA
11/2017 - 03/2017
2AdipokinesIBA
10/2016 - 06/2016
2Liposomes (Liposome)IBA
10/2016 - 06/2016
2Clodronic Acid (Clodronate)IBA
10/2016 - 06/2016
2Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2016 - 11/2015
2CpG ODN107IBA
01/2016 - 10/2012
2Small Interfering RNA (siRNA)IBA
01/2016 - 01/2016
2trichostatin A (A 300)IBA
01/2016 - 07/2013
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1LactamsIBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2017
1GlucocorticoidsIBA
09/2017
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2017
1Pyruvate KinaseIBA
10/2016
1Neutralizing AntibodiesIBA
10/2016
1Interleukin-18 (Interleukin 18)IBA
06/2016
1Transcription Factors (Transcription Factor)IBA
05/2016
1Pharmaceutical PreparationsIBA
05/2016
1Messenger RNA (mRNA)IBA
05/2016
1SpermidineIBA
01/2016
1OligodeoxyribonucleotidesIBA
01/2016
1Autophagy-Related ProteinsIBA
01/2016
1CPG-oligonucleotideIBA
01/2016
1Docetaxel (Taxotere)FDA Link
11/2015
1Caspase 3 (Caspase-3)IBA
03/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1AntibodiesIBA
01/2015
1SincalideFDA Link
02/2014
1GlutaminaseIBA
12/2013
1NAD (NADH)IBA
12/2013
1Glutathione (Reduced Glutathione)IBA
12/2013
1Histone Deacetylases (Histone Deacetylase)IBA
07/2013
1Histone Deacetylase InhibitorsIBA
07/2013
1Radiation-Sensitizing AgentsIBA
10/2012
1EnzymesIBA
03/2012
1ImmunosorbentsIBA
03/2012
1Fibronectins (Fibronectin)IBA
03/2012
1artemisinin (artemisinine)IBA
12/2011
1ArtesunateIBA
12/2011
1Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
07/2002
1DNA (Deoxyribonucleic Acid)IBA
07/2002

Therapy/Procedure

6Therapeutics
11/2017 - 03/2012
6Radiotherapy
01/2016 - 07/2002
3Drug Therapy (Chemotherapy)
05/2016 - 11/2015
1Transplantation
01/2016
1Chemoradiotherapy
11/2015
1Induction Chemotherapy
11/2015